EUVIMEDEUVIMED entdecken
Crossref

Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes

Lisa Rasbach iD, Ginna Purrington, Deanna Adkins, Robert Benjamin

The Science of Diabetes Self-Management and Care · 2025

DOI: 10.1177/26350106251361370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Science of Diabetes Self-Management and Care, 2025. Verfasst von Lisa Rasbach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, North Carolina. Hauptthemen laut MEDLINE: Telemedicine, Insulin Infusion Systems, Insulin, Hypoglycemic Agents. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Innovation Health Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study is to assess the effects of an intensive telehealth intervention on technology adoption and glycemic control in historically marginalized youth with diabetes mellitus on Medicaid.

Methods

This quality improvement project included youth (ages 12-18) with diabetes utilizing insulin therapy. Eligible participants were diagnosed at least 12 months prior to enrollment and had an A1C ≥9%, Medicaid insurance, and willingness to use a continuous glucose monitor (CGM) and an insulin pump. Participants received scheduled weekly contact (phone/video) with a certified diabetes care and education specialist and monthly video visits with a nurse practitioner.

Results

Youth (N = 18, 61% female, 78% non-White, diabetes duration 4.6±3 years) had baseline mean A1C of 11.4% ± 2.0%; 22% were on pump therapy. There was a sustained improvement between baseline A1C (mean 11.4% ± 2.0%) and 3 months (mean 10.5% ± 2.7%; P = .01) and 6 months (mean 9.8% ± 2.4%, 83.6 mmol/mol; P = .003). Significantly more participants used pump therapy by the end (n = 16) compared to baseline (n = 4; P < .0001). Participants wore CGMs more at 3 ( P = .04) and 6 months ( P = .0004) during the intervention compared to 3 and 6 months prior.

Conclusions

This telehealth intervention provided interim improvement in A1C and increased adoption of diabetes technology in a low socioeconomic status cohort from a historically marginalized population. Ongoing monitoring is needed to evaluate the durability of this intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineInsulin Infusion SystemsInsulinHypoglycemic AgentsDiabetes Mellitus, Type 1Diabetes MellitusHumansAdolescentFemaleChildMaleGlycated HemoglobinRisk FactorsBlood Glucose Self-MonitoringUnited StatesGlycemic ControlMedicaidBlood Glucose

Substanzen

InsulinHypoglycemic AgentsGlycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, North Carolina.

ORCID-Profile: Lisa Rasbach

Förderung

  • Innovation Health Grant

Zitieren

APA

Rasbach, L., Purrington, G., Adkins, D., & Benjamin, R. (2025). Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes. The Science of Diabetes Self-Management and Care. https://doi.org/10.1177/26350106251361370

Vancouver

Rasbach L, Purrington G, Adkins D, Benjamin R. Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes. The Science of Diabetes Self-Management and Care. 2025. doi:10.1177/26350106251361370

BibTeX
@article{Rasbach2025,
  author = {Rasbach, Lisa and Purrington, Ginna and Adkins, Deanna and Benjamin, Robert},
  title = {Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes},
  journal = {The Science of Diabetes Self-Management and Care},
  year = {2025},
  doi = {10.1177/26350106251361370}
}
Kostenlos starten →